Skip to content
Search

Latest Stories

NHS England awards £8.5m FDP contract to KPMG

NHS England awards £8.5m FDP contract to KPMG

Controversy sparked in November 2023 when NHS England awarded a £330 million contract for the FDP to US spy tech company Palantir 

NHS England has awarded an £8.5 million contract to consultancy firm KPMG "for technical support and implementation services" to help Integrated Care Boards (ICB) and NHS trusts in England to implement the Federated Data Platform (FDP) software.

According to the contract details published on Friday 12 April, KPMG "will support the NHSE Data Services team to not only build the Federated Data Platform (FDP) capability, but enhance the Data Service functions, platforms and integrating services to support the transformation change."


During the contract, which will extend until 17 March 2026, Additionally, the consultancy firm will assist ICBs and trusts in implementing their individual federated platforms, which will in turn feed into the national model.

NHSE ignited controversy in November 2023 when it granted a £330 million FDP contract to the US spy tech company Palantir, with concerns raised regarding the opaque nature of the tender process and the security of patient medical records.

On 22 December, NHS England published a heavily redacted version of its 586-page contract with Palantir to operate the platform.

After facing legal action from the Good Law Project, NHSE announced in March that it would republish its patient data contracts with Palantir with reduced redactions.

The legal campaign group also challenged NHS England over the extensive redactions in its contract with the bio-tech company IQVIA, which was awarded a £28m deal to provide “privacy enhancing technology” for the platform.

The Federated Data Platform software will enable NHS organisations to bring together operational data currently stored in separate systems, such as the number of beds in a hospital, the size of waiting lists for elective care services, or the availability of medical supplies, to support staff to access the information they need in one safe and secure environment.

NHSE has said that the FDP “will make it easier for staff at NHS trusts and integrated care boards (on behalf of integrated care systems (ICS) to access the information they need, freeing up valuable time to reinvest in delivering the best care possible for patients.”

“In the future, it will also enable Trusts and ICSs to make better use of the information they hold, supporting them to work together to understand patterns, solve problems, and plan services for their local populations,” it said.

As announced by the health service earlier, the implementation of the FDP will occur in stages spanning the next three years, beginning the transition phase from March to July 2024, followed by the delivery phase from May 2024 to March 2027. Once the transition phase proves successful, it will be gradually rolled out to new trusts and ICBs.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less